Cargando…
Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study
BACKGROUND: The pathological grading system for non-muscle-invasive bladder cancer is based on the WHO 2004/2016 classification system (low-grade: LG/high-grade: HG) and the WHO 1973 classification system (Grade 1: G1/Grade 2: G2/Grade 3: G3). Recently, the usefulness of combining both systems and c...
Autores principales: | Yamamoto, Akinaru, Kawashima, Atsunari, Uemura, Toshihiro, Yamamichi, Gaku, Tomiyama, Eisuke, Koh, Yoko, Matsushita, Makoto, Kato, Taigo, Hatano, Koji, Uemura, Motohide, Nonomura, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006582/ https://www.ncbi.nlm.nih.gov/pubmed/35413902 http://dx.doi.org/10.1186/s12894-022-01000-z |
Ejemplares similares
-
Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized Muscle-Invasive Bladder Cancer
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2022) -
TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020) -
Fragmentation of cell‐free DNA is induced by upper‐tract urothelial carcinoma–associated systemic inflammation
por: Nakano, Kosuke, et al.
Publicado: (2020) -
Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma
por: Uemura, Toshihiro, et al.
Publicado: (2023) -
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma
por: Koh, Yoko, et al.
Publicado: (2022)